Vectura erectile dysfunction drug test successful

LONDON, April 23 (Reuters) - British drug development firm Vectura Group Plc (VEC.L) said on Monday a phase two clinical study on its inhaled erectile dysfunction product had been successful.

Vectura said in the second double-blind placebo-controlled trial VR004 improved erectile performance, with a rapid onset of action, and was well tolerated.

((Reporting by Jonathan Cable

Editing by Erica Billingham

Reuters messaging: rm://jonathan.cable.reuters.com@reuters.net

Telephone +44 20 7542 4688

Email jonathan.cable@reuters.com)) Keywords: VECTURA TRIAL/

(C) Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nWLB7957GB/SMALL